Fresenius Medical Care AG & Co. KGaA (FMS)
NYSE: FMS · IEX Real-Time Price · USD
21.22
+0.18 (0.86%)
May 1, 2024, 4:00 PM EDT - Market closed
FMS Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for FMS stock has a target of 24, which predicts an increase of 13.10% from the current stock price of 21.22.
Analyst Consensus: Hold
* Price targets were last updated on Oct 11, 2023.
Analyst Ratings
The average analyst rating for FMS stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HSBC | HSBC | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Nov 24, 2023 |
Truist Securities | Truist Securities | Hold Maintains $28 → $24 | Hold | Maintains | $28 → $24 | +13.10% | Oct 11, 2023 |
Truist Securities | Truist Securities | Hold Maintains $26 → $28 | Hold | Maintains | $26 → $28 | +31.95% | Jul 13, 2023 |
Truist Securities | Truist Securities | Hold Maintains $24 → $26 | Hold | Maintains | $24 → $26 | +22.53% | May 10, 2023 |
Truist Securities | Truist Securities | Hold Maintains $22 → $24 | Hold | Maintains | $22 → $24 | +13.10% | Apr 13, 2023 |
Financial Forecast
Revenue This Year
19.95B
from 19.45B
Increased by 2.56%
Revenue Next Year
20.74B
from 19.95B
Increased by 3.93%
EPS This Year
2.80
from 0.85
Increased by 229.85%
EPS Next Year
3.52
from 2.80
Increased by 25.64%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 21.4B | 21.9B | 23.2B | 27.2B | 28.4B |
Avg | 20.0B | 20.7B | 21.6B | 23.7B | 25.0B |
Low | 18.8B | 19.2B | 19.7B | 21.9B | 22.8B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 9.9% | 9.8% | 11.8% | 26.0% | 19.7% |
Avg | 2.6% | 3.9% | 4.2% | 9.9% | 5.3% |
Low | -3.2% | -3.9% | -4.8% | 1.5% | -4.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 3.43 | 4.67 | 6.13 | 5.42 | 6.11 |
Avg | 2.80 | 3.52 | 4.12 | 4.66 | 5.37 |
Low | 2.16 | 2.64 | 3.51 | 3.80 | 4.73 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 303.9% | 66.7% | 74.1% | 31.4% | 31.0% |
Avg | 229.8% | 25.6% | 17.0% | 13.1% | 15.2% |
Low | 153.6% | -6.0% | -0.3% | -7.7% | 1.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.